Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    The press-release list now features October 2026 announcements about ELREXFIO’s Phase 3 results and TALZENNA plus XTANDI’s FDA approval. Older August 2026 releases about Pfizer’s Lyme disease vaccine candidate and the updated COVID-19 vaccine are no longer shown.
    Difference
    4%
    Check dated 2026-10-31T19:10:13.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The press-release listing now includes Pfizer’s report of robust Phase 2 results for its 25-valent pediatric pneumococcal vaccine candidate. It no longer lists the release reporting second-quarter results and updated 2026 revenue guidance.
    Difference
    0.9%
    Check dated 2026-10-24T22:26:59.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A new October 14, 2026 press release highlights Pfizer’s clinical advancements across infectious diseases at IDWeek. The July 2026 LITFULO Phase 3 results announcement and its related listing labels are no longer shown.
    Difference
    1%
    Check dated 2026-10-17T22:23:19.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The press releases page presents dated company announcements about medicines, research, vaccines, and financial updates, with category and archive-date filters. This replaces the prior security-verification screen.
    Difference
    100%
    Check dated 2026-10-10T22:16:16.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The press release archive, its listed releases, and surrounding navigation are absent from the newer view.
    Difference
    21%
    Check dated 2026-10-03T22:04:28.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The archive adds Finance and Financial categories and includes a new press release inviting the public to listen to a Pfizer Healthcare Conference webcast dated 09.15.2026. It also removes the Research and Research and Pipeline category and deletes the 06.22.2026 topline Phase 3 results press release for Sigvotatug Vedotin.
    Difference
    2%
    Check dated 2026-09-19T20:26:40.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.